Alimentiv Inc.
Clinical trials sponsored by Alimentiv Inc., explained in plain language.
-
Blood test aims to predict best Crohn's drug, boosting remission odds
Disease control Recruiting nowThis study is testing if a new blood test that analyzes epigenetic markers can help doctors choose the most effective biologic drug for adults with active Crohn's disease. About 378 participants will be randomly assigned to have their treatment selected either by this new test or…
Phase: NA • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Ultrasound-Guided Crohn's treatment aims for deeper healing
Disease control Recruiting nowThis study is testing whether aiming for 'transmural healing'—deep healing of the intestinal wall seen on ultrasound—leads to better results for people with moderate to severe Crohn's disease. About 304 participants will be randomly assigned to either have their treatment guided …
Phase: PHASE4 • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Study asks: how fast do Crohn's treatments really work?
Knowledge-focused Recruiting nowThis study aims to understand how quickly symptoms like pain, fatigue, and anxiety improve for people with Crohn's disease after starting specific biologic medications. Researchers will follow 300 adults who are beginning treatment with either vedolizumab or an IL-23 antagonist f…
Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Opening the door: First-Ever tools created for excluded Crohn's patients
Knowledge-focused Recruiting nowThis study aims to create new measurement tools so that people with Crohn's disease who have a permanent ileostomy can finally be included in future treatment trials. Researchers will work with about 50 participants to develop two tools: one based on patient interviews about thei…
Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC